Mangalam Drugs and Organics is currently trading at RS 81.00, up by 0.81 points or 1.01% from its previous closing of RS 80.19 on the BSE.

The stock opened at RS 80.19 and recorded a high of RS 84.19 and a low of RS 79.79. A total of 737 shares have been traded so far.

A BSE group 'B' stock with a face value of RS 10, Mangalam Drugs has touched a 52-week high of RS 144.65 on August 26, 2024, and a 52-week low of RS 65.50 on June 30, 2025. Over the last week, the scrip registered a high of RS 84.19 and a low of RS 79.72. The company’s market capitalization currently stands at RS 128.21 crore.

The shareholding pattern shows promoters holding 50.30%, institutions 0.53%, and non-institutions 49.16%.

In a key development, Mangalam Drugs and Organics has secured a major export order valued at $21,81,040 from a reputed international client. This order is expected to strengthen the company’s global presence and boost its revenue growth in the coming quarters.

The company continues to focus on delivering high-quality pharmaceutical products to domestic and international markets, thereby enhancing its shareholder value.

Mangalam Drugs and Organics is an India-based manufacturer engaged in the production of chemicals, active pharmaceutical ingredients (APIs), perfumery, disperse dye intermediates, bulk drugs, and bulk drug intermediates.